Huadong Medicine Co Ltd (000963) - Total Liabilities
Based on the latest financial reports, Huadong Medicine Co Ltd (000963) has total liabilities worth CN¥15.43 Billion CNY (≈ $2.26 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Huadong Medicine Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Huadong Medicine Co Ltd - Total Liabilities Trend (1997–2024)
This chart illustrates how Huadong Medicine Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 000963 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Huadong Medicine Co Ltd Competitors by Total Liabilities
The table below lists competitors of Huadong Medicine Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Alkermes Plc
NASDAQ:ALKS
|
USA | $2.51 Billion |
|
Advanced Fiber Resources Zhuhai Ltd
SHE:300620
|
China | CN¥1.62 Billion |
|
Merlin Properties SOCIMI SA
MC:MRL
|
Spain | €5.99 Billion |
|
Vietnam Prosperity Joint Stock Commercial Bank
VN:VPB
|
Vietnam | ₫1185.41 Trillion |
|
Pearson plc
F:PESA
|
Germany | €2.79 Billion |
|
Shanghai Putailai New Energy Technology Co.Ltd.
SHG:603659
|
China | CN¥26.89 Billion |
|
Telekom Malaysia Bhd
KLSE:4863
|
Malaysia | RM23.84 Million |
|
Svenska Cellulosa Aktiebolaget SCA (publ)
ST:SCA-B
|
Sweden | Skr44.94 Billion |
Liability Composition Analysis (1997–2024)
This chart breaks down Huadong Medicine Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Huadong Medicine Co Ltd market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.56 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.64 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Huadong Medicine Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Huadong Medicine Co Ltd (1997–2024)
The table below shows the annual total liabilities of Huadong Medicine Co Ltd from 1997 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥14.32 Billion ≈ $2.09 Billion |
+20.02% |
| 2023-12-31 | CN¥11.93 Billion ≈ $1.75 Billion |
-0.74% |
| 2022-12-31 | CN¥12.02 Billion ≈ $1.76 Billion |
+19.50% |
| 2021-12-31 | CN¥10.06 Billion ≈ $1.47 Billion |
+11.45% |
| 2020-12-31 | CN¥9.02 Billion ≈ $1.32 Billion |
+4.94% |
| 2019-12-31 | CN¥8.60 Billion ≈ $1.26 Billion |
-2.21% |
| 2018-12-31 | CN¥8.79 Billion ≈ $1.29 Billion |
+22.48% |
| 2017-12-31 | CN¥7.18 Billion ≈ $1.05 Billion |
+5.34% |
| 2016-12-31 | CN¥6.81 Billion ≈ $997.19 Million |
-16.63% |
| 2015-12-31 | CN¥8.17 Billion ≈ $1.20 Billion |
+25.97% |
| 2014-12-31 | CN¥6.49 Billion ≈ $949.48 Million |
+39.29% |
| 2013-12-31 | CN¥4.66 Billion ≈ $681.65 Million |
+11.00% |
| 2012-12-31 | CN¥4.20 Billion ≈ $614.10 Million |
+3.64% |
| 2011-12-31 | CN¥4.05 Billion ≈ $592.52 Million |
+39.16% |
| 2010-12-31 | CN¥2.91 Billion ≈ $425.80 Million |
+27.91% |
| 2009-12-31 | CN¥2.27 Billion ≈ $332.88 Million |
+3.42% |
| 2008-12-31 | CN¥2.20 Billion ≈ $321.87 Million |
+21.00% |
| 2007-12-31 | CN¥1.82 Billion ≈ $266.01 Million |
+13.82% |
| 2006-12-31 | CN¥1.60 Billion ≈ $233.71 Million |
+16.85% |
| 2005-12-31 | CN¥1.37 Billion ≈ $200.02 Million |
+22.09% |
| 2004-12-31 | CN¥1.12 Billion ≈ $163.83 Million |
+40.47% |
| 2003-12-31 | CN¥797.04 Million ≈ $116.63 Million |
+4.44% |
| 2002-12-31 | CN¥763.14 Million ≈ $111.67 Million |
+15.08% |
| 2001-12-31 | CN¥663.14 Million ≈ $97.04 Million |
+5.75% |
| 2000-12-31 | CN¥627.09 Million ≈ $91.76 Million |
+24.94% |
| 1999-12-31 | CN¥501.93 Million ≈ $73.45 Million |
+7.60% |
| 1998-12-31 | CN¥466.47 Million ≈ $68.26 Million |
+9.47% |
| 1997-12-31 | CN¥426.13 Million ≈ $62.36 Million |
-- |
About Huadong Medicine Co Ltd
Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosup… Read more